GlassScriptPhysician profile
Kimberly Mchugh
NPI 1750770772
$4,296.58
in general payments reported to CMS, 2019-2025
30 companies · $1,082 in 2025
The $1,082 reported for 2025 was more than what 86% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $579 · 2022: $1,011 · 2023: $826 · 2024: $799 · 2025: $1,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,608 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,607.64 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,283.80 | 2021-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $804.40 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Electromed, INC. | $420.77 | 2021-2024 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $350.23 | 2021-2025 | Ofev, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $170.55 | 2023-2025 | Dupixent |
| Genzyme Corporation | $152.23 | 2022-2025 | |
| Insmed, INC. | $151.06 | 2024-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $143.06 | 2024-2025 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $110.04 | 2021-2024 | Yupelri |
| Verona Pharma, INC. | $89.48 | 2025 | Ohtuvayre |
| Neurelis, INC. | $89.40 | 2022 | |
| Inogen, INC. | $48.28 | 2024-2025 | |
| Vifor Pharma, INC. | $47.80 | 2025 | Zemaira |
| Pfizer INC. | $44.81 | 2025 | |
| Amgen INC. | $42.22 | 2024-2025 | Tavneos, Tezspire |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $36.68 | 2021 | |
| Ani Pharmaceuticals, INC. | $36.04 | 2024 | Purified Cortrophin Gel |
| Baxter Healthcare | $34.86 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Novartis Pharmaceuticals Corporation | $28.68 | 2023 | |
| Philips North America LLC | $28.61 | 2024 | (Ak6) Vest Therapy |
| Vapotherm INC | $24.91 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.65 | 2024 | Glassia |
| Invivyd INC | $20.64 | 2025 | Pemgarda |
| Bayer Healthcare Pharmaceuticals INC. | $19.79 | 2021 | |
| Advanced Respiratory, INC | $18.55 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.97 | 2021 | |
| Medtronic, INC. | $16.67 | 2024 | O-Arm |
| Gilead Sciences, INC. | $14.36 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.30 | 2024 | Nuzyra |
| Genentech USA, INC. | $13.74 | 2023 | Xolair, Actemra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Mchugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.